Allied Market Research
Loading...
0
 

Jarvik Heart, Inc.-Company profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report

  • ID: CPS__175997
  • July 2017
  • 8 pages
  • Price: $ 95
 
 

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).

 

TOC

1.1 Company Overview

1.2 Company Snapshot

1.3 Operating Business Segment

1.4 Business Performance

1.5 Key Strategic moves and Development

 

LIST OF TABLES & FIGURES

TABLE 1. JARVIK HEART: COMPANY SNAPSHOT

FIG. 1. JARVIK HEART: SWOT ANALYSIS

PURCHASE OPTIONS

 

 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts